-
2
-
-
0026673155
-
Risk of and prophylaxis for venous thromboembolism in hospital patients
-
Thromboembolic Risk Factors (THRIFT) Consensus Group Risk of and prophylaxis for venous thromboembolism in hospital patients BMJ 305 1992 567 574
-
(1992)
BMJ
, vol.305
, pp. 567-574
-
-
Thromboembolic Risk Factors (THRIFT) Consensus Group1
-
3
-
-
0026893311
-
Prevention of venous thromboembolism
-
European Consensus Statement Prevention of venous thromboembolism Int Angiol 11 1992 151 159
-
(1992)
Int Angiol
, vol.11
, pp. 151-159
-
-
European Consensus Statement1
-
4
-
-
85113055273
-
Pathogenesis of arterial thrombosis
-
La Harker M. Gent Pathogenesis of arterial thrombosis 3rd ed Rw Colman J. Hirsh Vj Marder Ew Salzman Hemostasis and thrombosis: basic principles and clinical practice 1994 JB Lippincott Philadelphia
-
(1994)
-
-
Harker, La1
Gent, M.2
-
5
-
-
0026434005
-
Heparin
-
J. Hirsh Heparin N Engl J Med 324 1991 1565 1574
-
(1991)
N Engl J Med
, vol.324
, pp. 1565-1574
-
-
Hirsh, J.1
-
6
-
-
0026593425
-
Low molecular weight heparin
-
J. Hirsh Mn Levine Low molecular weight heparin Blood 79 1992 1 17
-
(1992)
Blood
, vol.79
, pp. 1-17
-
-
Hirsh, J.1
Levine, Mn2
-
7
-
-
0025146426
-
Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
-
Ji Weitz M. Hudoba D. Massel J. Maraganore J. Hirsh Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors J Clin Invest 86 1990 385 391
-
(1990)
J Clin Invest
, vol.86
, pp. 385-391
-
-
Weitz, Ji1
Hudoba, M.2
Massel, D.3
Maraganore, J.4
Hirsh, J.5
-
8
-
-
0026720153
-
The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model
-
P. Klement A. Borm J. Hirsh J. Maraganore G. Wilson Ji Weitz The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model Thromb Haemost 68 1992 64 68
-
(1992)
Thromb Haemost
, vol.68
, pp. 64-68
-
-
Klement, P.1
Borm, A.2
Hirsh, J.3
Maraganore, J.4
Wilson, G.5
Weitz, Ji6
-
9
-
-
0028092111
-
Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial
-
Em Antman TIMI 9A Investigators Hirudin in acute myocardial infarction: safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial Circulation 90 1994 1624 1630
-
(1994)
Circulation
, vol.90
, pp. 1624-1630
-
-
Antman, Em1
TIMI 9A Investigators2
-
11
-
-
84951658626
-
Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) Study
-
Kl Neuhaus Rv Essen U. Tebbe Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) Study Circulation 90 1994 1632 1642
-
(1994)
Circulation
, vol.90
, pp. 1632-1642
-
-
Neuhaus, Kl1
Essen, Rv2
Tebbe, U.3
|